儿童肾病综合征中LAMA5基因的遗传变异
该研究对300个儿童肾病综合征家庭进行全外显子测序,在3个疑似隐性单基因病因且已知肾病基因突变被排除的家庭中检出LAMA5纯合意义未明变异。患者均为早发非综合征型肾病综合征,但临床结局与免疫抑制治疗反应差异显著;作者认为这些变异可能是贡献于儿童肾病综合征发生的遗传因素,尚需更多数据确定其临床影响。
要点
- 儿童肾病综合征中LAMA5纯合意义未明变异可能为隐性遗传贡献因素。
- 携带LAMA5变异者均为早发非综合征型肾病综合征,治疗反应差异显著。
- LAMA5变异对疾病管理的意义尚不明确,需更多数据验证。
核心结论
- 在部分治疗部分有效的儿童肾病综合征患者中鉴定出LAMA5基因隐性意义未明变异。
- 家族聚集、遗传定位数据及重现肾病综合征表型的小鼠模型提示这些变异可能贡献于儿童肾病综合征发生。
- 这些变异对疾病管理的影响尚需更多数据确定。
研究设计与样本
- 对300个儿童肾病综合征家庭行全外显子测序。
- 在近亲婚配家庭中应用纯合子定位以识别潜在隐性突变位点。
- 在3个已知肾病基因突变被排除但依据家系信息强烈怀疑隐性单基因病因的家庭中分析LAMA5变异。
主要发现
- 在3个家庭中检出LAMA5纯合意义未明变异。
- 所有受累个体均为早发非综合征型肾病综合征。
- 受累个体的临床结局与免疫抑制治疗反应差异显著。
关键数值与推荐
- 儿童期起病肾病综合征中约15%对激素治疗无反应,归类为激素抵抗型肾病综合征(SRNS)。
- 约30%的SRNS病例可在44个单基因SRNS基因之一中检出致病突变。
- LAMA5编码层粘连蛋白α5,为肾小球基底膜的重要成分;其直系同源基因Lama5亚效突变小鼠出现蛋白尿和血尿。
临床怎么用
- 对已知肾病基因突变被排除、家系提示隐性单基因病因的儿童肾病综合征,可考虑LAMA5变异检测。
- 检出LAMA5意义未明变异时,应结合家系共分离与临床表型谨慎解读,不宜直接用于治疗决策。
局限性
- 检出的LAMA5变异为意义未明变异,致病性尚未确定。
- 仅3个家庭受累,样本量小。
- 作者指出尚需更多数据确定这些变异对疾病管理的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nephrotic syndrome (NS), a chronic kidney disease, is characterized by significant loss of protein in the urine causing hypoalbuminemia and edema. In general, ∼15% of childhood-onset cases do not respond to steroid therapy and are classified as steroid-resistant NS (SRNS). In ∼30% of cases with SRNS, a causative mutation can be detected in one of 44 monogenic SRNS genes. The gene LAMA5 encodes laminin-α5, an essential component of the glomerular basement membrane. Mice with a hypomorphic mutation in the orthologous gene Lama5 develop proteinuria and hematuria. METHODS: To identify additional monogenic causes of NS, we performed whole exome sequencing in 300 families with pediatric NS. In consanguineous families we applied homozygosity mapping to identify genomic candidate loci for the underlying recessive mutation. RESULTS: In three families, in whom mutations in known NS genes were excluded, but in whom a recessive, monogenic cause of NS was strongly suspected based on pedigree information, we identified homozygous variants of unknown significance (VUS) in the gene LAMA5. While all affected individuals had nonsyndromic NS with an early onset of disease, their clinical outcome and response to immunosuppressive therapy differed notably. CONCLUSION: We here identify recessive VUS in the gene LAMA5 in patients with partially treatment-responsive NS. More data will be needed to determine the impact of these VUS in disease management. However, familial occurrence of disease, data from genetic mapping and a mouse model that recapitulates the NS phenotypes suggest that these genetic variants may be inherited factors that contribute to the development of NS in pediatric patients.
引用
- Braun DA, Warejko JK, Ashraf S, et al. Genetic variants in the LAMA5 gene in pediatric nephrotic syndrome. Nephrol Dial Transplant. 2019. PMID: 29534211. doi:10.1093/ndt/gfy028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。